Jpmorgan Chase & Co »

Gt Biopharma shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $4 1 4.00

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Gt Biopharma

Vanguard Group
Bank Of Montreal
Geode Capital Management
BlackRock
Wells Fargo & Company
Tower Research Capital
UBS Group
Morgan Stanley
FMR
Advisor Group Holdings
Bank of America Corporation
Blue Bell Private Wealth Management
Royal Bank of Canada
Bnp Paribas Arbitrage, Snc
Jpmorgan Chase & Co

View all funds holding Gt Biopharma